Literature DB >> 21263455

Epidemiology of valvular heart disease in the adult.

Bernard Iung1, Alec Vahanian.   

Abstract

Valvular heart disease remains common in industrialized countries, because the decrease in prevalence of rheumatic heart diseases has been accompanied by an increase in that of degenerative valve diseases. Aortic stenosis and mitral regurgitation are the two most common types of valvular disease in Europe. The prevalence of valvular disease increases sharply with age, owing to the predominance of degenerative etiologies. The burden of heart valve disease in the elderly has an important impact on patient management, given the high frequency of comorbidity and the increased risk associated with intervention in this age group. Endocarditis is an important etiology of valvular disease and is most commonly caused by Staphylococci. Rheumatic heart disease remains prevalent in developing countries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263455     DOI: 10.1038/nrcardio.2010.202

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  85 in total

Review 1.  The aortic root: structure, function, and surgical reconstruction.

Authors:  M J Underwood; G El Khoury; D Deronck; D Glineur; R Dion
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

2.  Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve.

Authors:  K L Chan; M Ghani; K Woodend; I G Burwash
Journal:  Am J Cardiol       Date:  2001-09-15       Impact factor: 2.778

3.  The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening.

Authors:  John E Cosmi; Smadar Kort; Paul A Tunick; Barry P Rosenzweig; Robin S Freedberg; Edward S Katz; Robert M Applebaum; Itzhak Kronzon
Journal:  Arch Intern Med       Date:  2002-11-11

4.  Rate of change in aortic valve area during a cardiac cycle can predict the rate of hemodynamic progression of aortic stenosis.

Authors:  S J Lester; D B McElhinney; J P Miller; J T Lutz; C M Otto; R F Redberg
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

5.  Prognosis of carcinoid heart disease: analysis of 200 cases over two decades.

Authors:  Jacob E Møller; Patricia A Pellikka; Alain M Bernheim; Hartzell V Schaff; Joseph Rubin; Heidi M Connolly
Journal:  Circulation       Date:  2005-11-14       Impact factor: 29.690

6.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease).

Authors:  Patrizio Lancellotti; Christophe Tribouilloy; Andreas Hagendorff; Luis Moura; Bogdan A Popescu; Eustachio Agricola; Jean-Luc Monin; Luc A Pierard; Luigi Badano; Jose L Zamorano
Journal:  Eur J Echocardiogr       Date:  2010-04

7.  Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.

Authors:  Martyn Thomas; Gerhard Schymik; Thomas Walther; Dominique Himbert; Thierry Lefèvre; Hendrik Treede; Holger Eggebrecht; Paolo Rubino; Iassen Michev; Rüdiger Lange; William N Anderson; Olaf Wendler
Journal:  Circulation       Date:  2010-06-21       Impact factor: 29.690

8.  Changing profile of infective endocarditis: results of a 1-year survey in France.

Authors:  Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

9.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

10.  Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Authors:  Kwan Leung Chan; Koon Teo; Jean G Dumesnil; Andy Ni; James Tam
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more
  144 in total

1.  Is comorbidity equivalent to symptoms in asymptomatic AS?

Authors:  Daniyar Gilmanov; Annamaria Mazzone; Sergio Berti; Mattia Glauber
Journal:  Nat Rev Cardiol       Date:  2011-11-25       Impact factor: 32.419

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Standard transthoracic echocardiography and transesophageal echocardiography views of mitral pathology that every surgeon should know.

Authors:  Timothy C Tan; Judy W Hung
Journal:  Ann Cardiothorac Surg       Date:  2015-09

4.  COX2 inhibition reduces aortic valve calcification in vivo.

Authors:  Elaine E Wirrig; M Victoria Gomez; Robert B Hinton; Katherine E Yutzey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-26       Impact factor: 8.311

Review 5.  Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies.

Authors:  J W Simpkins; S-H Yang; Y Wen; M Singh
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

6.  Disturbed energy and amino acid metabolism with their diagnostic potential in mitral valve disease revealed by untargeted plasma metabolic profiling.

Authors:  Limiao Jiang; Jing Wang; Rui Li; Ze-Min Fang; Xue-Hai Zhu; Xin Yi; Hongwen Lan; Xiang Wei; Ding-Sheng Jiang
Journal:  Metabolomics       Date:  2019-04-01       Impact factor: 4.290

7.  Strategies to Improve Survival from Surgery for Heart Valve Implantation in Sheep.

Authors:  Annemijn Vis; Jan Cam Lammers; Roel de Vroege; Martijn Mj van Nieuwburg; Marlijn S Jansen; Joyce Mj Visser; Bart Meuris; Paul F Gründeman; Jolanda Kluin
Journal:  Comp Med       Date:  2021-06-03       Impact factor: 0.982

Review 8.  [Transcatheter aortic valve implantation (TAVI)].

Authors:  H Möllmann; W-K Kim; T Walther; C Hamm
Journal:  Internist (Berl)       Date:  2013-12       Impact factor: 0.743

9.  Management of severe pulmonary hypertension in patients undergoing mitral valve surgery.

Authors:  Carlos D Davila; Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

10.  Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis.

Authors:  Teresa Trenkwalder; Christopher P Nelson; Muntaser D Musameh; Ify R Mordi; Thorsten Kessler; Costanza Pellegrini; Radoslaw Debiec; Tobias Rheude; Viktor Lazovic; Lingyao Zeng; Andreas Martinsson; J Gustav Smith; Jesper R Gådin; Anders Franco-Cereceda; Per Eriksson; Jonas B Nielsen; Sarah E Graham; Cristen J Willer; Kristian Hveem; Adnan Kastrati; Peter S Braund; Colin N A Palmer; Amparo Aracil; Oliver Husser; Wolfgang Koenig; Heribert Schunkert; Chim C Lang; Christian Hengstenberg; Nilesh J Samani
Journal:  Int J Cardiol       Date:  2018-11-17       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.